Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA advisory committee recommends approval of Prandin

Nov. 20, 1997

New ACAT inhibitor from Pierre Fabre

Nov. 20, 1997

Insulin therapy found useful in patients with type II diabetes

Nov. 20, 1997

Pseudopeptide derivatives of OGP and OGP(10-14) disclosed by Yissum

Nov. 20, 1997

Patent coverage obtained for SomatoKine in osteoporosis, tissue repair

Nov. 20, 1997

rhIGF-I + insulin combination tested in adolescents with IDDM

Nov. 19, 1997

Schering-Plough obtains rights to Vasomax

Nov. 18, 1997

SomatoKine shows potential for the treatment of osteoporosis

Nov. 18, 1997

Pharmacokinetic profile of Taisho's ACAT inhibitor

Nov. 18, 1997

Roche resubmits NDA for Xenical

Nov. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...